LNTH Revenue Flow Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.
2026-06-30: Revenue $388.18M ; Cost of revenue $146.32M ; Research and development $38.20M ; Operating expenses (m) . 2026-03-31: Revenue $377.33M ; Cost of revenue $146.41M ; Research and development $39.38M ; Operating expenses (m) . 2025-12-31: Revenue $406.79M* ; Cost of revenue $165.91M* ; Research and development $47.48M* ; Operating expenses (m) . 2025-09-30: Revenue $384.01M ; Cost of revenue $161.65M ; Research and development $48.02M ; Operating expenses (m) . Product or service Separate filed amounts; connecting flows are not established. Components and totals may overlap.
LNTH revenue flow Filed amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow. Product $376.93M Cardiology $88.28M Definity $88.28M Licenseand Royalty Revenues $11.25M Neuraceq $39.62M Neurology $39.62M Oncology $240.37M PYLARIFY $240.37M SPECT Business $0.00 Strategic Partnerships And Other $19.92M Revenue $388.18M Cost of revenue $146.32M Gross profit $241.86M Operating income $100.22M Other income, net $7.86M Research & development $38.20M Pre-tax income $93.82M Income tax $18.80M Net income $75.03M
Geography Separate filed amounts; connecting flows are not established. Components and totals may overlap.
LNTH revenue flow Filed amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow. Non Us $19.89M US $368.29M Revenue $388.18M Cost of revenue $146.32M Gross profit $241.86M Operating income $100.22M Other income, net $7.86M Research & development $38.20M Pre-tax income $93.82M Income tax $18.80M Net income $75.03M
Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.
Historical revenue and expense breakdown Revenue and expense 3 month Period end Revenue Cost of revenue Research and development Operating expenses Income tax Net income 2026-06-30 $388.18M $146.32M $38.20M (m) $18.80M $75.03M 2026-03-31 $377.33M $146.41M $39.38M (m) $37.99M $118.42M 2025-12-31 $406.79M* $165.91M* $47.48M* (m) $16.28M* $54.09M* 2025-09-30 $384.01M $161.65M $48.02M (m) $14.61M $27.77M 2025-06-30 $378.05M $137.03M $45.49M (m) $25.76M $78.75M 2025-03-31 $372.76M $135.06M $36.31M (m) $23.58M $72.94M 2024-09-30 $378.73M $136.61M $24.15M (m) $45.02M $131.09M 2024-06-30 $394.09M $138.32M $60.60M (m) $22.30M $62.07M 2024-03-31 $369.98M $128.13M $48.02M (m) $40.20M $131.07M 2023-09-30 $319.95M $120.00M $14.45M (m) $28.00M $131.96M 2023-06-30 $321.70M $119.05M $15.90M (m) $29.56M $94.13M 2023-03-31 $300.78M $223.71M $30.53M (m) -$8.30M -$2.81M 2022-09-30 $239.29M $91.86M $12.52M (m) $21.78M $61.23M 2022-06-30 $223.72M $85.69M $14.73M (m) $18.99M $43.06M 2022-03-31 $208.88M $79.81M $12.20M (m) $14.94M $42.96M 2021-09-30 $102.07M $59.40M $11.25M (m) -$6.42M -$13.41M 2021-06-30 $101.06M $54.98M $12.06M (m) -$1.88M -$26.66M 2021-03-31 $92.51M $51.48M $10.36M (m) $5.33M $9.01M 2020-09-30 $88.54M $52.28M $11.68M (m) -$1.08M -$6.39M 2020-06-30 $66.01M $40.16M $4.42M (m) $309.00K -$7.01M 2020-03-31 $90.70M $52.70M $4.05M (m) $2.19M $3.34M 2019-12-31 $89.35M (m) (m) (m) (m) $10.45M 2019-09-30 $85.78M $44.19M $4.86M (m) $501.00K $4.86M 2019-06-30 $85.70M $41.13M $5.79M (m) $1.70M $6.41M 2019-03-31 $86.51M $42.43M $4.93M (m) $2.81M $9.95M 2018-12-31 $86.27M (m) (m) (m) $4.00M $13.29M 2018-09-30 $88.90M $44.02M $4.32M (m) $3.57M $9.27M 2018-06-30 $85.57M $41.73M $4.21M (m) $2.22M $9.74M 2018-03-31 $82.63M $40.32M $3.99M (m) $3.80M $8.21M 2017-12-31 $81.24M (m) (m) (m) (m) $97.13M 2017-09-30 $79.94M $41.41M $3.55M (m) $762.00K $8.53M 2017-06-30 $88.84M $42.89M $5.24M (m) $569.00K $13.60M 2017-03-31 $81.36M (m) $5.35M (m) $785.00K $4.14M 2016-12-31 $74.35M (m) (m) (m) (m) $4.87M 2016-09-30 $73.06M (m) $2.85M (m) $20.00K $4.22M 2016-06-30 $77.97M (m) $2.61M (m) $247.00K $7.35M 2016-03-31 $76.47M (m) $3.04M $21.86M $390.00K $10.32M 2015-12-31 $71.20M (m) (m) $20.99M* (m) $3.92M 2015-09-30 $74.12M (m) $2.46M $20.30M $739.00K $5.39M 2015-06-30 $73.31M (m) $2.64M $27.31M $1.18M -$24.42M 2015-03-31 $74.82M (m) $6.20M $24.39M -$3.00K $375.00K 2014-12-31 $76.97M (m) (m) (m) (m) $227.00K 2014-09-30 $75.68M (m) $3.05M $22.42M -$56.00K -$867.00K 2014-06-30 $75.61M (m) $2.69M $21.08M $874.00K -$1.64M 2014-03-31 $73.34M (m) (m) (m) (m) -$1.28M
Revenue and expense 6 month Period end Revenue Cost of revenue Research and development Operating expenses Income tax Net income 2026-06-30 $765.51M $292.74M $77.58M (m) $56.78M $193.45M 2025-06-30 $750.81M $272.10M $81.80M (m) $49.35M $151.70M 2024-06-30 $764.07M $266.45M $108.63M (m) $62.50M $193.14M 2023-06-30 $622.48M $342.76M $46.43M (m) $21.26M $91.32M 2022-06-30 $432.60M $165.50M $26.94M (m) $33.93M $86.02M 2021-06-30 $193.57M $106.45M $22.42M (m) $3.46M -$17.65M 2020-06-30 $156.71M $92.86M $8.47M (m) $2.50M -$3.67M 2019-06-30 $172.22M $83.56M $10.72M (m) $4.51M $16.36M 2018-06-30 $168.20M $82.05M $8.20M (m) $6.01M (m) 2017-06-30 $170.20M $84.49M $10.60M (m) $1.35M (m) 2016-06-30 $154.44M (m) $5.64M (m) $637.00K (m) 2015-06-30 $148.14M (m) $8.83M $51.70M $1.17M (m) 2014-06-30 $148.95M (m) $5.91M $42.65M -$318.00K (m)
Revenue and expense 9 month Period end Revenue Cost of revenue Research and development Operating expenses Income tax Net income 2025-09-30 $1.13B $433.75M $129.83M (m) $63.96M $179.47M 2024-09-30 $1.14B $403.05M $132.77M (m) $107.53M $324.23M 2023-09-30 $942.43M $462.76M $60.88M (m) $49.26M $223.28M 2022-09-30 $671.89M $257.36M $39.45M (m) $55.71M $147.25M 2021-09-30 $295.65M $165.86M $33.67M (m) -$2.97M -$31.06M 2020-09-30 $245.26M $145.15M $20.15M (m) $1.43M -$10.06M 2019-09-30 $257.99M $127.75M $15.58M (m) $5.01M $21.22M 2018-09-30 $257.10M $126.06M $12.52M (m) $9.58M (m) 2017-09-30 $250.14M $125.90M $14.15M (m) $2.12M (m) 2016-09-30 $227.50M (m) $8.49M (m) $657.00K (m) 2015-09-30 $222.26M (m) $11.29M $72.00M $1.91M (m) 2014-09-30 $224.63M (m) $8.96M $65.07M -$374.00K (m)
Revenue and expense 12 month Period end Revenue Cost of revenue Research and development Operating expenses Income tax Net income 2025-12-31 $1.54B $599.66M $177.31M (m) $80.23M $233.56M 2024-12-31 $1.53B $545.62M $168.10M (m) $118.53M $312.44M 2023-12-31 $1.30B $586.89M $77.71M (m) $84.28M $326.66M 2022-12-31 $935.06M $353.36M $311.68M (m) -$1.35M $28.07M 2021-12-31 $425.21M $237.51M $44.97M (m) -$3.76M -$71.28M 2020-12-31 $339.41M $200.65M $32.79M $142.96M $1.99M -$13.47M 2019-12-31 $347.34M $172.53M $20.02M $123.15M -$3.04M $31.67M 2018-12-31 $343.37M $168.49M $17.07M $110.40M $9.03M $40.52M 2017-12-31 $331.38M $169.24M $18.13M $110.28M -$83.75M $123.39M 2016-12-31 $301.85M $164.07M $12.20M (m) $1.53M (m) 2015-12-31 $293.46M (m) $14.36M $92.99M $2.97M (m) 2014-12-31 $301.60M (m) $13.67M $86.10M $1.20M (m) 2013-12-31 $283.67M (m) $30.46M $96.25M $1.01M (m)